$TMO (Thermo Fisher Scientific, Inc.)

$TMO {{ '2016-04-04T23:22:49+0000' | timeago}} • Announcement

$TMO said that it has priced an offering of $1Bil aggregate principal amount of 3.000% senior notes due 2023 at an issue price of 99.512% of the principal amount. The issuance of the notes is expected to close on or about April 13, 2016.

$TMO {{ '2017-08-29T13:21:17+0000' | timeago}} • Announcement

$TMO said it completed the acquisition of $PTHN for approx. $7.2Bil. For the remainder of 2017, the transaction is expected to be approx. $0.09 accretive to adjusted EPS, which includes $0.02 in 3Q17.

$TMO {{ '2017-08-23T20:33:41+0000' | timeago}} • Announcement

$TMO, a biotech company, announced that all required antitrust clearances have been obtained for the previously announced all-cash tender offer by its wholly owned subsidiary, Thermo Fisher (CN) Luxembourg, to purchase all of the outstanding ordinary shares of $PTHN, a pharma company. The firm expects to complete the tender offer on Aug 28, 2017.

$TMO {{ '2017-08-11T12:09:46+0000' | timeago}} • Announcement

$TMO has priced an offering of $750MM aggregate principal amount of its 3.2% senior notes due 2027 and $750MM aggregate principal amount of 4.1% senior notes due 2047. The offer is expected to close on August 14. The company intends to use the proceeds of the offering to fund a portion of the consideration payable for the acquisition of $PTHN.

$TMO {{ '2017-08-09T18:26:30+0000' | timeago}} • Announcement

$TMO priced its underwritten public offering of 8.77MM shares of common stock at $171 per share for gross proceeds of approx. $1.5Bil. The underwriters are given 30-day option to purchase 1.32MM more shares. The issue will end on Aug 11, 2017. A portion of its acquisition of $PTHN, to be closed by 3Q17-end, will be funded with the proceeds.

$TMO {{ '2017-08-07T20:44:48+0000' | timeago}} • Announcement

$TMO's subsidiary Thermo Fisher (CN) Luxembourg has extended the offering period of its all-cash tender offer to buy all of outstanding ordinary shares of $PTHN. $TMO now expects to complete the transaction around the end of 3Q17. The tender offer is now scheduled to expire on Aug. 28, 2017, unless extended or earlier terminated.

$TMO {{ '2017-08-07T20:32:39+0000' | timeago}} • Announcement

$TMO has commenced an underwritten public offering of $1.5Bil of its common stock. The company plans to use the net proceeds from the offering to fund a portion of the consideration payable for the acquisition of $PTHN, including repayment of Patheon’s debt. The acquisition is expected to close by the end of 3Q17.

$TMO {{ '2017-07-26T14:06:23+0000' | timeago}} • Webcast

$TMO said the upward revision of 2017 financial outlook mainly reflected the less adverse foreign exchange environment. The company continues to expect 4% organic revenue growth for the year. Excluding the effect of foreign exchange headwinds, adjusted EPS is seen growing 12-14%. Adjusted operating margin is forecast to grow 50-60 basis points YoY.

$TMO {{ '2017-07-26T13:46:17+0000' | timeago}} • Webcast

Scientific equipment maker $TMO said pharma and biotec continued to be its strongest end markets in 2Q17, with mid-single digits growth. The company's growth strategy remains centered on launching innovative products and leveraging the scale in Asia Pacific and emerging markets. In 2Q17, Thermo Fisher completed $250MM of share buybacks.

$TMO {{ '2017-07-26T12:48:19+0000' | timeago}} • Infographic

$TMO Thermo Fisher Scientific, Inc. Earnings AlphaGraphic: Q2 2017 highlights

$TMO {{ '2017-07-26T10:56:26+0000' | timeago}} • Announcement

Among $TMO’s business segments, Life Sciences Solutions posted a 3% YoY growth in 2Q17 revenues. Analytical Instruments segment revenues surged 47%, reflecting the acquisition of FEI Company last year. Revenues of the Specialty Diagnostics segment and Laboratory Products & Services segment advanced 1% and 4%, respectively, compared to 2Q16.

$TMO {{ '2017-07-26T10:42:34+0000' | timeago}} • Announcement

$TMO revised up its fiscal 2017 revenue guidance to the range of $19.71-$19.89Bil from the previous outlook of $19.51-$19.71Bil, indicating an 8-9% annual growth. The guidance of adjusted EPS has been raised to $9.15-$9.28 per share from the earlier forecast of $9.12-$9.28 per share, which will result in an 11-12% YoY increase.

$TMO {{ '2017-07-26T10:33:50+0000' | timeago}} • Announcement

Medical instruments maker $TMO reported strong results for 2Q17, continuing the recent trend. Earnings of the company, which is currently on an acquisition spree, jumped 20% YoY to $1.56 per share. Adjusted earnings, excluding special items, grew 13% to $2.3 per share. The bottom line growth was driven by a 10% increase in revenues to $4.99Bil.

$TMO {{ '2017-07-19T12:44:47+0000' | timeago}} • Announcement

$TMO priced an offering of EUR2.6Bil of senior notes. The issuance of the notes is expected to close on or about July 24, 2017. $TMO plans to use all of net proceeds to fund a portion of consideration payable for its acquisition of Patheon, including the repayment of debt of Patheon to be assumed by $TMO, which is estimated to be about $7.2Bil.

$TMO {{ '2017-07-12T21:02:58+0000' | timeago}} • Announcement

$TMO declared a quarterly cash dividend of $0.15 per share, payable on October 16, 2017, to shareholders of record as of September 15, 2017.

$TMO {{ '2017-05-18T13:12:12+0000' | timeago}} • Announcement

$TMO declared a quarterly cash dividend of $0.15 per share. The dividend will be paid on July 17, 2017, to shareholders of record as of June 15, 2017.

$TMO {{ '2017-04-26T14:19:48+0000' | timeago}} • Webcast

For 2017, $TMO expects modest organic growth for its microarray business. The company said it has launched a number of products and commercial initiatives for that business and that will help build some momentum moving through the course of 2017.

$TMO {{ '2017-04-26T14:13:04+0000' | timeago}} • Webcast

$TMO said roughly half of the margin expansion within Analytical Instruments segment in 1Q17 came from FEI acquisition. There is a good volume pull through in that segment and expects to drive additional revenue using the PPI (practical process improvement) business system, added the company.

$TMO {{ '2017-04-26T11:16:21+0000' | timeago}} • Announcement

In 1Q17, $TMO's revenue from Life Sciences Solutions segment grew 12% to $1.36Bil, while that from Analytical Instruments segment grew 39% to $1.05Bil. In other segments, Specialty Diagnostics revenue grew 1% to $866MM, and Laboratory Products and Services revenue grew 3% to $1.70Bil.

$TMO {{ '2017-04-26T11:11:01+0000' | timeago}} • Announcement

$TMO raised its revenue guidance for FY17 to a new range of $19.51-19.71Bil vs its original guidance of $19.38-19.62Bil announced in January 2017. Adjusted EPS guidance was raised to a range of $9.12-9.28 vs the $9.06-9.24 previously communicated.

$TMO {{ '2017-04-26T11:06:50+0000' | timeago}} • Announcement

Biotechnology product development company $TMO posted 11% growth in revenue to $4.77Bil in 1Q17. Organic revenue growth was 4%. Net income was $551.4MM, or $1.40 per share, better than $402MM, or $1.01 per share in 1Q16. Excluding one-off costs, net income rose to $2.08 per share.

Recent Transcripts

AIRI (Air Industries Group)
Wednesday, August 16 2017 - 8:00pm
VJET (Voxeljet AG)
Tuesday, August 15 2017 - 12:30pm
VRML (Vermillion, Inc.)
Wednesday, August 9 2017 - 8:30pm
CVU (CPI Aerostructures Inc.)
Tuesday, August 8 2017 - 12:30pm
INTT (inTEST Corp.)
Thursday, August 3 2017 - 9:00pm
TDY (Teledyne Technologies Inc.)
Thursday, August 3 2017 - 3:00pm
TNC (Tennant Company)
Wednesday, August 2 2017 - 3:00pm
THR (Thermon Group Holdings, Inc.)
Wednesday, August 2 2017 - 3:00pm
ILMN (Illumina Inc.)
Tuesday, August 1 2017 - 8:30pm
LBY (Libbey Inc.)
Tuesday, August 1 2017 - 3:00pm
XYL (Xylem Inc.)
Tuesday, August 1 2017 - 1:00pm
SNE (Sony Corporation)
Tuesday, August 1 2017 - 8:15am
CGNX (Cognex Corporation)
Monday, July 31 2017 - 9:00pm
ROP (Roper Technologies, Inc.)
Monday, July 31 2017 - 12:30pm
MTD (Mettler-Toledo International Inc.)
Thursday, July 27 2017 - 8:30pm
ABAX (Abaxis, Inc.)
Thursday, July 27 2017 - 8:15pm
APH (Amphenol Corporation)
Wednesday, July 26 2017 - 5:00pm
IEX (IDEX Corporation)
Wednesday, July 26 2017 - 2:30pm
F (Ford Motor Co.)
Wednesday, July 26 2017 - 1:00pm
TMO (Thermo Fisher Scientific, Inc.)
Wednesday, July 26 2017 - 12:30pm

AlphaGraphics you may like